|4.||Psoriasis (Pustulosis Palmaris et Plantaris)
|5.||Rheumatic Diseases (Rheumatism)
|1.||Menzies, Dick: 18 articles (01/2015 - 08/2004)|
|2.||Pai, Madhukar: 16 articles (10/2014 - 12/2004)|
|3.||Lalvani, Ajit: 16 articles (02/2014 - 11/2002)|
|4.||Wilkinson, Robert J: 13 articles (03/2015 - 05/2005)|
|5.||Nienhaus, Albert: 10 articles (01/2014 - 05/2007)|
|6.||Wilkinson, Katalin A: 9 articles (03/2015 - 11/2002)|
|7.||Daley, Charles L: 9 articles (01/2014 - 10/2002)|
|8.||Banaei, Niaz: 8 articles (09/2015 - 04/2011)|
|9.||Chaisson, Richard E: 8 articles (01/2014 - 07/2002)|
|10.||Diel, R: 8 articles (11/2012 - 01/2006)|
|1.||Isoniazid (Ftivazide)FDA LinkGeneric
01/01/2013 - "Patient adherence to isoniazid (INH) monotherapy for latent tuberculosis infection (LTBI) has been suboptimal despite its proven efficacy. "
09/15/2007 - "A 9-month course of isoniazid monotherapy is currently recommended for the treatment of latent tuberculosis infection (LTBI) and has been shown to be effective in both children and adults. "
05/01/2010 - "Isoniazid (INH) has been the mainstay of treatment of latent tuberculosis infection for almost 50 years. "
03/05/2010 - "Since the 1960s, 6 to 9 months of isoniazid (INH) has been the mainstay of treatment for latent tuberculosis infection (LTBI), but its application has been limited by concerns about the toxicity of INH and the long duration of treatment. "
08/15/2003 - "In summary, we conclude that in our clinic population isoniazid is a safe therapy for latent tuberculosis, but its effectiveness is limited by modest completion rates."
04/01/2012 - "Purified protein derivative (PPD) has served as a safe and effective diagnostic reagent for 60 years and is the only broadly available material to diagnose latent tuberculosis infections. "
05/01/2007 - "The aim of this study was to compare the efficacy of the tuberculin skin test (TST) and the quantiferon test (QFT) for detecting latent tuberculosis infection (LTBI) in health care workers (HCWs). "
06/01/2007 - "Screening for latent tuberculosis infection (LTBI) with the Mantoux tuberculin skin test (TST) has many limitations including false-positive results due to Mycobacterium bovis bacillus Calmette-Guérin (BCG) vaccination. "
01/01/2002 - "To assess the efficacy of tuberculin skin screening for TB in schoolchildren in southwestern Israel as well as the compliance to treatment for latent tuberculosis infection. "
12/01/2013 - "Providing detailed information about latent tuberculosis and compliance with the PPD test among healthcare workers in Israel: a randomized controlled study."
|3.||Interferon-gamma (Interferon, gamma)IBA
07/01/2012 - "Although Mantoux test is the most used, IGRA (Interferon-gamma Release Assays) tests seem to give good results for presumptive diagnosis of active or latent tuberculosis. "
07/01/2015 - "Determining the accuracy of interferon gamma-release assays (IGRAs) is difficult due to the lack of a gold standard test for diagnosing latent tuberculosis (LTB). "
08/01/2013 - "Despite increased use and accuracy of interferon-gamma release assays to detect latent tuberculosis infection (LTBI) in foreign-born arrivals in the United States, risk characteristics associated with positive results are not well characterized. "
01/01/2014 - "As a result of the study it is suggested to confirm positive TST results with tests based on interferon-gamma (IFN-γ) because it can reduce false positive diagnosis and treatment of latent tuberculosis infection, thus adverse reactions of drugs, in countries where BCG vaccination is routinely recommended especially for low risk children."
01/01/2013 - "The objective of our study was to conduct a systematic review of methodologic aspects of CEA that evaluate Interferon Gamma Release Assays (IGRA) for the detection of Latent Tuberculosis Infection (LTBI), in order to understand how differences affect study results. "
12/01/2015 - "PpiA antigen specific immune response is a potential biomarker for latent tuberculosis infection."
11/01/2015 - "Diagnostic value of antibody responses to multiple antigens from Mycobacterium tuberculosis in active and latent tuberculosis."
08/01/2015 - "Immune responses to latent tuberculosis antigen Rv2659c in Chinese populations."
07/01/2015 - "Differential expression of CD57 in antigen-reactive CD4+ T cells between active and latent tuberculosis infection."
02/04/2015 - "We investigated factors associated with latent tuberculosis infection (LTBI) and with cytokine response to mycobacterial antigen at age five years. "
01/01/2015 - "Interferon-γ release assays (IGRAs) offer the possibility of improved detection of latent tuberculosis infection (LTBI). "
08/15/2012 - "Identifying predictors of interferon-γ release assay results in pediatric latent tuberculosis: a protective role of bacillus Calmette-Guerin?: a pTB-NET collaborative study."
09/17/2011 - "[Interferon-γ-based assays: can we optimize the diagnosis of latent tuberculosis infection in contact tracing studies?]."
04/01/2015 - "Interferon-γ release assays (IGRAs) are increasingly used for the diagnosis of latent tuberculosis infection (LTBI). "
01/01/2015 - "Latent tuberculosis: interferon and beyond?"
|6.||Rifampin (Rifampicin)FDA LinkGeneric
06/01/2014 - "Successful rifampin desensitization in a pediatric patient with latent tuberculosis."
11/01/2011 - "Tolerability of rifampin monotherapy for latent tuberculosis infection in children."
07/01/2010 - "Treating latent tuberculosis with rifampin: is it the cheaper option?"
05/01/2009 - "Rifampin hepatotoxicity associated with treatment of latent tuberculosis infection is rare. "
05/01/2009 - "Rifampin hepatotoxicity associated with treatment of latent tuberculosis infection."
02/01/2010 - "Cost-effectiveness of the NICE guidelines for screening for latent tuberculosis infection: the QuantiFERON-TB Gold IGRA alone is more cost-effective for immigrants from high burden countries."
08/01/2009 - "Targeted screening and treatment for latent tuberculosis infection using QuantiFERON-TB Gold is cost-effective in Mexico."
01/01/2011 - "The response rate for this study was 90.8% with 954 respondents completed the questionnaire and were tested with Quantiferon TB Gold in tube for latent tuberculosis infection. "
01/01/2010 - "The objective of the study was to determine IFN-γ responses for the detection of latent tuberculosis infection (LTBI) with QuantiFERON-TB GOLD In Tube (QFT-G-IT) and T-SPOT.TB in HIV patients, and evaluate the influence of CD4 cell count on tests performance. "
01/01/2010 - "The study population comprises 287 HCWs, who participated in routine occupational safety and health screening for latent tuberculosis infection (LTBI) with the QuantiFERON-TB(®) Gold In-Tube assay (QFT). "
07/23/2002 - "The current Canadian and US guidelines for the treatment of multidrug-resistant latent tuberculosis infection advocate the use of pyrazinamide and a fluoroquinolone as a first-line treatment option. "
10/15/2005 - "Because earlier randomized trials of rifampin-pyrazinamide lacked adequate statistical power to detect fatal events, the Centers for Disease Control and Prevention recommends that rifampin-pyrazinamide generally should not be used for treatment of latent tuberculosis infection."
08/15/2004 - "Rifampin and pyrazinamide for latent tuberculosis infection: clinical trials and general practice."
05/01/2004 - "A 2-month regimen of rifampin and pyrazinamide (2RZ) became an accepted alternative for treatment of latent tuberculosis (TB) after initial studies in HIV-seropositive patients demonstrated safety and efficacy. "
02/01/2007 - "Safety of the rifampin and pyrazinamide short-course regimen for treating latent tuberculosis infection."
|9.||rifapentine (Priftin)FDA Link
01/01/2011 - "Rifapentine-based regimens for treating latent tuberculosis infection (LTBI) are being considered for future clinical trials, but even if they prove effective, high drug costs may limit their economic viability. "
06/01/2002 - "Rifapentine 900-mg, once-weekly dosing appears to be safe and well tolerated and is being evaluated in Phase III efficacy trials of treatment of latent tuberculosis. "
09/01/1999 - "In this study we measured the efficacies of rifapentine-containing intermittent drug regimens for preventive therapy using the Cornell mouse model of latent tuberculosis. "
10/01/2015 - "Rifapentine for latent tuberculosis infection treatment in the general population and human immunodeficiency virus-positive patients: summary of evidence."
06/01/2014 - "Use of higher weight-adjusted rifapentine doses for young children are warranted to achieve systemic exposures that are associated with successful treatment of latent tuberculosis infection in adults."
01/01/2010 - "Previous studies have demonstrated the efficacy of treatment for latent tuberculosis infection (TLTBI) in persons infected with the human immunodeficiency virus, but few studies have investigated the operational aspects of implementing TLTBI in the co-infected population.The"
01/01/2012 - "Of the eight persons with HIV, one was newly diagnosed and co-infected with latent tuberculosis; he was treated for latent TB and linked to an HIV provider. "
07/01/2013 - "IDUs co-infected with HIV and tuberculosis (TB) have a high risk of progression from latent tuberculosis infection (LTBI) to active TB. "
01/01/2013 - "HIV shows high co-morbidity with tuberculosis (TB), as HIV stimulates the reactivation of latent tuberculosis (TB). "
12/01/2009 - "Latent tuberculosis is defined by the absence of clinical symptoms but carries a risk of subsequent progression to clinical disease, particularly in the context of co-infection with HIV. "
05/01/2012 - "Contacts with latent tuberculosis infection (LTBI) are offered chemoprophylaxis to prevent active disease; however, the effectiveness of this intervention is unclear as treatment completion is generally low. "
01/01/2012 - "In addition we estimated that one person receives chemoprophylaxis for latent tuberculosis infection (LTBI) for every three TB cases. "
05/01/2007 - "[Randomized clinical trial investigating three chemoprophylaxis regimens for latent tuberculosis infection in HIV-infected patients]."
01/01/2006 - "At that stage the closest occupational contacts had been screened, all of whom were assessed as being free from active disease, and none had met nationally recommended criteria for chemoprophylaxis for latent tuberculosis infection (LTBI). "
01/01/2004 - "It is known that treatment of latent tuberculosis infection (LTBI), also referred to as preventive therapy or chemoprophylaxis, helps to prevent progression to active disease in human immunodeficiency virus (HIV) negative populations. "
|2.||Drug Therapy (Chemotherapy)
11/01/2009 - "As few data exist on the mechanisms of latent tuberculosis, it is important to examine latent tuberculosis in terms of pathogenesis and efficacy of chemotherapy. "
10/01/2013 - "This study analyzed the degree of adherence with and safety of the treatment of latent tuberculosis infection (TLTBI) in oncohematological patients undergoing antineoplastic chemotherapy. "
11/01/2009 - "As human samples are hardly available to study latent tuberculosis, our guinea pig model would be useful for examining the pathogenesis and molecular mechanisms of latent tuberculosis as well as for monitoring the results of chemotherapy with green fluorescence emission of tubercle bacilli."
01/01/2008 - "The practical value of chemotherapy for latent tuberculosis infection in the megapolis requires studies and evidence-based results. "
05/01/2007 - "Further studies are now needed to determine if a greater clinical benefit from IFN-gamma could be obtained for the prophylactic treatment of latent tuberculosis infection and for shortening of the protracted standard chemotherapy regimen. "
01/01/2012 - "Improvement in psoriasis after treatment of reactivated latent tuberculosis following initiation of TNF-α inhibitor therapy has yet to be described in the literature. "
02/01/2014 - "In this symposium, we learned the seriousness of infection and disease among immune-suppressed groups, special environmental factors with regard to the spread of infection, disease after treatment of latent tuberculosis infection, diagnostic specification of IGRA, and bacteriological features including genotyping of the bacilli. "
01/01/2012 - "Levels of interferon-gamma increase after treatment for latent tuberculosis infection in a high-transmission setting."
01/01/2006 - "Persistently elevated T cell interferon-gamma responses after treatment for latent tuberculosis infection among health care workers in India: a preliminary report."
04/01/2004 - "We suggest that diagnosis of latent tuberculosis infection is important before treatment with Infliximab is initiated and that antituberculous medication must be prescribed immediately in case of occurrence of unexplained fever after treatment with Infliximab."
|4.||Renal Dialysis (Hemodialysis)
05/01/2015 - "We selected studies with adequate information to ascertain test sensitivity or specificity of the TST, QFT-G, and TSPOT.TB with regards to determining latent tuberculosis infection in the hemodialysis population. "
05/01/2015 - "The objective of this study is to evaluate the diagnostic accuracy of these tests in determining latent tuberculosis infection in the hemodialysis population. "
07/01/2014 - "This study aimed to compare the ability of the TST and IGRA in the diagnosis of latent tuberculosis in hemodialysis patients and investigate risk factors of having positive test results. "
05/01/2015 - "The QFT-G and the T-SPOT.TB tests were more sensitive than the TST for diagnosis of latent tuberculosis infection in patients on hemodialysis while offering a comparable level of specificity. "
05/01/2015 - "The diagnostic accuracy of tests for latent tuberculosis infection in hemodialysis patients: a systematic review and meta-analysis."
06/27/2007 - "In this study, treatment of latent tuberculosis during transplant candidacy period is explored, and relevant literature is reviewed. "
10/01/2015 - "The standard treatment of latent tuberculosis infection (LTBI) is associated with toxicities and data are limited on tolerability among patients with advanced organ disease listed for transplant. "
10/01/2015 - "Latent tuberculosis in kidney and liver transplant patients: a review of treatment practices and outcomes."
09/27/2014 - "Screening and therapy of latent tuberculosis infection (LTBI) is recommended in solid organ transplant (SOT). "
09/27/2014 - "Outcome of latent tuberculosis infection in solid organ transplant recipients over a 10-year period."